Molybdenum dithiocarbamate (MoDTC) is a well-known lubricant additive, which, in tribological conditions, is capable of forming layers of MoS 2 with excellent friction reduction properties. Despite being widely employed in commercial engine oils, a comprehensive theoretical description of the properties of MoDTC is still lacking. In this work, we employ density functional theory to study the structural, electronic, and vibrational properties of MoDTC. We investigate the relative stability of different isomers, different hydrocarbon terminations, and oxidized complexes. Oxidation was found to be energetically favorable for a wide range of conditions, and the most favorable position for oxygen atoms in MoDTC turned out to be the ligand position. These results, along with the calculated reaction energies for different dissociation paths, can be useful to better identify the elementary steps of the decomposition process of MoDTC.
The
remarkable lubricant properties of molybdenum dithiocarbamates
(MoDTCs) make this class of oil additives well-known in the automotive
industry. However, the mechanism of function of these compounds is
still not completely understood at the atomistic level. We provide
new insights into the dissociation of MoDTCs in tribological conditions,
which are the key to describe the debated mechanism to form MoS2. Quantum mechanics/molecular mechanics (QM/MM) dynamic simulations
allowed us to monitor in real time the tribochemical reactions occurring
at the iron interface and revealed that the presence of the iron substrate
and the mechanical stresses alter the dissociation path with respect
to what is expected for the isolated MoDTC molecules. Moreover, they
uncovered the important role of molecular oxidation on the dissociation
pattern: the presence of oxygen atoms in the ligand position of MoDTCs
favors the release of the central units of the molecules, containing
just Mo and S atoms with the correct stoichiometry to form MoS2. This work demonstrates how the predictive power of ab initio
simulations can be very valuable to design new lubricant additives.
Molybdenum dithiocarbamates
(MoDTCs) are a class of lubricant additives
widely employed in automotives. Most of the studies concerning MoDTC
take into account the dimeric structures because of their industrial
relevance, with the mononuclear compounds usually neglected, because
isolating and characterizing subgroups of MoDTC molecules are generally
difficult. However, the byproducts of the synthesis of MoDTC can impact
the friction reduction performance at metallic interfaces, and the
effect of mononuclear MoDTC (mMoDTC) compounds in the lubrication
has not been considered yet in the literature. In this study, we consider
for the first time the impurities of MoDTC consisting of mononuclear
compounds and combine experimental and computational techniques to
elucidate the interaction of these impurities with binuclear MoDTC
in commercial formulations. We present a preliminary strategy to separate
a commercial MoDTC product in chemically different fractions. These
fractions present different tribological behaviors depending on the
relative amount of mononuclear and binuclear complexes. The calculations
indicate that the dissociation mechanism of mMoDTC is similar to the
one observed for the dimeric structures. However, the different chemical
properties of mMoDTC impact the kinetics for the formation of the
beneficial molybdenum disulfide (MoS
2
) layers, as shown
by the tribological experiments. These results help to understand
the functionality of MoDTC lubricant additives, providing new insights
into the complex synergy between the different chemical structures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.